Myroslav Zapukhlyak

About Myroslav Zapukhlyak

Myroslav Zapukhlyak, With an exceptional h-index of 12 and a recent h-index of 10 (since 2020), a distinguished researcher at Westfälische Wilhelms-Universität Münster, specializes in the field of Bioinformatics, Biophysics, Atomic and Molecular Physics, Computational Physics, Nanophysics.

His recent articles reflect a diverse array of research interests and contributions to the field:

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms

P1227: COMPREHENSIVE MOLECULAR SUBTYPING OF DIFFUSE LARGE B-CELL LYMPHOMA CELL LINES AND ASSOCIATION WITH TAFASITAMAB ACTIVITY

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma

Combination treatment targeting mTOR and MAPK pathways has synergistic activity in multiple myeloma

Molecular profiling of EBV associated diffuse large B-cell lymphoma

Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age

Myroslav Zapukhlyak Information

University

Position

___

Citations(all)

551

Citations(since 2020)

333

Cited By

295

hIndex(all)

12

hIndex(since 2020)

10

i10Index(all)

13

i10Index(since 2020)

11

Email

University Profile Page

Google Scholar

Myroslav Zapukhlyak Skills & Research Interests

Bioinformatics

Biophysics

Atomic and Molecular Physics

Computational Physics

Nanophysics

Top articles of Myroslav Zapukhlyak

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma

Leukemia

2023/1

Myroslav Zapukhlyak
Myroslav Zapukhlyak

H-Index: 5

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms

Leukemia

2023/10

P1227: COMPREHENSIVE MOLECULAR SUBTYPING OF DIFFUSE LARGE B-CELL LYMPHOMA CELL LINES AND ASSOCIATION WITH TAFASITAMAB ACTIVITY

HemaSphere

2023/8/1

Myroslav Zapukhlyak
Myroslav Zapukhlyak

H-Index: 5

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma

Frontiers in immunology

2023/7/31

Myroslav Zapukhlyak
Myroslav Zapukhlyak

H-Index: 5

Stefan Steidl
Stefan Steidl

H-Index: 32

Combination treatment targeting mTOR and MAPK pathways has synergistic activity in multiple myeloma

Cancers

2023/4/19

Ling Jin
Ling Jin

H-Index: 2

Myroslav Zapukhlyak
Myroslav Zapukhlyak

H-Index: 5

Molecular profiling of EBV associated diffuse large B-cell lymphoma

Leukemia

2023/3

Myroslav Zapukhlyak
Myroslav Zapukhlyak

H-Index: 5

Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial

Leukemia

2022/10

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age

Nature communications

2022/7/6

Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL

Blood, The Journal of the American Society of Hematology

2021/9/9

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma

Nature Communications

2021/8/31

The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions

Proceedings of the National Academy of Sciences

2020/10/20

Myroslav Zapukhlyak
Myroslav Zapukhlyak

H-Index: 5

Lymphoma angiogenesis is orchestrated by noncanonical signaling pathways

Cancer Research

2020/3/15

Marleen Gloger
Marleen Gloger

H-Index: 3

Myroslav Zapukhlyak
Myroslav Zapukhlyak

H-Index: 5

Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma

Blood, The Journal of the American Society of Hematology

2020/1/9

See List of Professors in Myroslav Zapukhlyak University(Westfälische Wilhelms-Universität Münster)